亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白
Recombinant Leucine Rich Alpha-2-Glycoprotein 1 (LRG1)
- 編號(hào)RPB934Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱(chēng)，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量47.1kDa
- 實(shí)際分子量47kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Leu37~Leu342 with Two N-terminal Tags, His-tag and SUMO-tag
- 緩沖液成份100mMNaHCO3, 500mMNaCl, pH8.3, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)6.1
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB934Mu02 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu03 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB934Mu01 | 亮氨酸豐富α2-糖蛋白1(LRG1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB934Mu01 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB934Mu03 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB934Mu02 | 亮氨酸豐富α2-糖蛋白1(LRG1)多克隆抗體 | WB; IHC; ICC; IP. |
| SEB934Mu | 亮氨酸豐富α2-糖蛋白1(LRG1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB934Mu | 亮氨酸豐富α2-糖蛋白1(LRG1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome [PubMed: 26351173] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study [pubmed:28112944] |
| OncoTargets?and Therapy | leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter [Pubmed:29785123] |
| PROTEOMICS?– Clinical Applications | Screening and Identification of Pregnancy Zone Protein (PZP) and Leucine‐Rich Alpha‐2‐Glycoprotein (LRG) as Potential Serum Biomarkers for Early‐onset?… [Pubmed: 30411527] |
| Cancer Management and Research | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia [Pubmed: 31440093] |
| J Clin Med | A Three-Protein Panel to Support the Diagnosis of Sepsis in Children [Pubmed:35329889] |
留言咨詢(xún)
